Novel Contractual Arrangements in the Pharmaceutical Industry

制药行业的新型合同安排

基本信息

  • 批准号:
    RGPIN-2017-04089
  • 负责人:
  • 金额:
    $ 2.99万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2020
  • 资助国家:
    加拿大
  • 起止时间:
    2020-01-01 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

The primary objective of this program of research is to develop a number of mathematical models to study novel and important contractual arrangements in the pharmaceutical industry. I will focus on three main areas: 1. Risk sharing contracts between drug companies and third-party payers; 2. Contracts that could be used to increase the supply of essential medicines in low-income countries; 3. Contracts that could be used to ensure smooth supply of medicines in high-income countries. The three areas identified above are similar in that: 1. They all may involve contracts between a payer (such as an insurance company, a government healthcare payer or a non-governmental organization(NGO); 2. Various forms of “outcomes based” contracts have been proposed as solutions for each type of problem; and 3. There may be serious unintended consequences from policy proposals that sound rational. For each subtopic I will investigate a number of proposed and potential contracts between payers and pharmaceutical companies (manufacturers). Key questions of this analysis include some of the following: What are the likely intentional and unintended effects of various contract structures? For a given contract structure, what is the optimal way to structure payments? How do different contract structures compare in terms of cost, performance, and other useful metrics? Note that the primary focus is not on health or health delivery. Rather, the focus is on understanding the structure and behavior of the contracts themselves, and how they influence the incentives of parties participating in the contracts.
该研究项目的主要目标是开发一些数学模型,以研究制药行业中新颖而重要的合同安排。我将集中讨论三个主要方面:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zaric, Gregory其他文献

Zaric, Gregory的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zaric, Gregory', 18)}}的其他基金

Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2022
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2021
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2019
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2018
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
"Optimal Pricing, Purchasing, and Co-Development with Applications in Public and Private Sector Pharmaceutical Management"
“优化定价、采购和共同开发及其在公共和私营部门药品管理中的应用”
  • 批准号:
    228649-2012
  • 财政年份:
    2016
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
"Optimal Pricing, Purchasing, and Co-Development with Applications in Public and Private Sector Pharmaceutical Management"
“优化定价、采购和共同开发及其在公共和私营部门药品管理中的应用”
  • 批准号:
    228649-2012
  • 财政年份:
    2015
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
"Optimal Pricing, Purchasing, and Co-Development with Applications in Public and Private Sector Pharmaceutical Management"
“优化定价、采购和共同开发及其在公共和私营部门药品管理中的应用”
  • 批准号:
    228649-2012
  • 财政年份:
    2014
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
"Optimal Pricing, Purchasing, and Co-Development with Applications in Public and Private Sector Pharmaceutical Management"
“优化定价、采购和共同开发及其在公共和私营部门药品管理中的应用”
  • 批准号:
    429676-2012
  • 财政年份:
    2014
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Accelerator Supplements
"Optimal Pricing, Purchasing, and Co-Development with Applications in Public and Private Sector Pharmaceutical Management"
“优化定价、采购和共同开发及其在公共和私营部门药品管理中的应用”
  • 批准号:
    228649-2012
  • 财政年份:
    2013
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
"Optimal Pricing, Purchasing, and Co-Development with Applications in Public and Private Sector Pharmaceutical Management"
“优化定价、采购和共同开发及其在公共和私营部门药品管理中的应用”
  • 批准号:
    429676-2012
  • 财政年份:
    2013
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Accelerator Supplements

相似海外基金

Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2022
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2021
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
A Study on Digital Platform Transactions: Focusing on the Contractual Aspects
数字平台交易研究:关注合同方面
  • 批准号:
    21H00670
  • 财政年份:
    2021
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2019
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
Economics of Contract and a Theory of Contractual Liability
合同经济学和合同责任理论
  • 批准号:
    18K01339
  • 财政年份:
    2018
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Contractual Arrangements in the Pharmaceutical Industry
制药行业的新型合同安排
  • 批准号:
    RGPIN-2017-04089
  • 财政年份:
    2018
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Discovery Grants Program - Individual
Research on Non-Contractual Liability Arising out of Damage Caused by Dangerous Things
危险物造成损害的非合同责任研究
  • 批准号:
    17K03443
  • 财政年份:
    2017
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
IntelPact - Contractual obligation extraction using artificial intelligence
IntelPact - 使用人工智能提取合同义务
  • 批准号:
    104100
  • 财政年份:
    2017
  • 资助金额:
    $ 2.99万
  • 项目类别:
    EU-Funded
Contractual obligation extraction using artificial intelligence
使用人工智能提取合同义务
  • 批准号:
    103023
  • 财政年份:
    2017
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Feasibility Studies
CRISP Type 2/Collaborative Research: Multi-Agent Sustainable Water Decision Theory (MUST): Nexus of Water, Road, and Hierarchic Social Contractual Systems
CRISP 类型 2/协作研究:多主体可持续水决策理论 (MUST):水、道路和分层社会契约系统的关系
  • 批准号:
    1638320
  • 财政年份:
    2016
  • 资助金额:
    $ 2.99万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了